Management of Depressive Pseudodementia with Antidepressants and Psychotherapy

Primary Treatment Approach

• The American College of Physicians recommends starting with SSRIs as first-line antidepressants, as they have minimal anticholinergic side effects that could worsen cognition, with fluoxetine demonstrating efficacy in randomized controlled trials for improving depressive symptoms in patients with depressive pseudodementia 1
• The treatment approach should avoid anticholinergic medications, as they can worsen cognition and increase confusion in patients with depressive pseudodementia 2

Pharmacological and Psychotherapy Treatment

• Combining antidepressants with psychotherapy is recommended for optimal outcomes in mood disorders without suicidal risk, and considering referral to social work and chaplaincy services for additional support in patients with depressive pseudodementia 1
• Psychostimulant drugs may help manage associated fatigue that often accompanies depression in patients with depressive pseudodementia 1

Treatment Response and Monitoring

• Evaluate treatment response within 4-6 weeks using validated assessment tools, as most patients show improvement in cognitive scores following antidepressant treatment, confirming the reversible nature of depressive pseudodementia 2